Floatz logo

Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Oxodotreotide
Plasma Cell Myeloma
Jules Bordet InstituteP1CC (43)
Oxodotreotide
Nasopharyngeal Carcinoma
National Cancer Institute (NCI)P1CC (43)
Oxodotreotide
Olfactory Neuroblastoma
National Cancer Institute (NCI)P1CC (43)
Oxodotreotide
Pancreatic Neoplasm
National Cancer Institute (NCI)P1CC (43)
Oxygen
Cluster Headache Syndrome
The University of Texas Health Science Center, HoustonP1CC (43)
Oxygen
Hemicrania Continua
The University of Texas Health Science Center, HoustonP1CC (43)
Oxygen
Paroxysmal Hemicrania
The University of Texas Health Science Center, HoustonP1CC (43)
Oxygen
SUNCT Syndrome
The University of Texas Health Science Center, HoustonP1CC (43)
Oxygen
Trigeminal Autonomic Cephalalgia
The University of Texas Health Science Center, HoustonP1CC (43)
p95her2.car-tech2me
Endometrial Cancer
Vall d'Hebron Institute of OncologyP1CC (43)
p95her2.car-tech2me
Gastric Cancer
Vall d'Hebron Institute of OncologyP1CC (43)
Pace Cart19
Acute Lymphoblastic Leukemia
University of PennsylvaniaP1CC (43)
Pace Cart19
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
University of PennsylvaniaP1CC (43)
Pace Cart19
Non-Hodgkin Lymphoma
University of PennsylvaniaP1CC (43)
Palazestrant
Metastatic Prostate Carcinoma
Olema Pharmaceuticals, Inc.P1CC (43)
Palazestrant
Non-Small Cell Lung Carcinoma
Olema Pharmaceuticals, Inc.P1CC (43)
Palbociclib
Amyotrophic Lateral Sclerosis Type 19
M.D. Anderson Cancer CenterP1CC (43)
Palbociclib
Retinoblastoma
Brown UniversityP1CC (43)
Pamiparib
Low Grade Glioma
University of California, San FranciscoP1CC (43)
Panda-Vac
Head And Neck Squamous Cell Carcinoma
UNC Lineberger Comprehensive Cancer CenterP1CC (43)
Panda-Vac
Squamous Cell Lung Carcinoma
UNC Lineberger Comprehensive Cancer CenterP1CC (43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Renal Pelvis Urothelial Carcinoma
National Cancer Institute (NCI)P1CC (43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Ureter Transitional Cell Carcinoma
National Cancer Institute (NCI)P1CC (43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Urethra Transitional Cell Carcinoma
National Cancer Institute (NCI)P1CC (43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Malignant Renal Pelvis Neoplasm
National Cancer Institute (NCI)P1CC (43)
Showing 3701 to 3725 of 9,920 assets
PreviousPage 149 of 397Next